ISTH 2020 CONGRESS: CANCER-ASSOCIATED THROMBOSIS ABSTRACT OVERVIEW
The recent International Society on Thrombosis and Haemostasis (ISTH) Congress, held on 12–14 July 2020, was a great...
LATEST ARTICLES
PATIENTS’ EXPERIENCE OF LIVING WITH CANCER-ASSOCIATED THROMBOSIS: THE PELICAN PROJECT
The clinical issues and the main consequences of venous thromboembolism (VTE) in patients with cancer are nowadays well...
COVID-19 Hemostasis and Malignancy: the Bergamo Experience
The COVID-19 pandemic took one of its biggest tolls on Italy, and especially in the northern area, in Lombardy. In this...
The Art of Managing Cancer-Associated Thrombosis: Caravaggio and Beyond
Venous thromboembolism (VTE) is a frequent complication and the second leading cause of death in cancer patients....
Fundamental research in oncology and thrombosis – the Frontline experience
What is the physician perception and common practice in treatment of venous thromboembolism (VTE) in cancer patients?...
Toward the replacement of low-molecular-weight heparins with the novel direct oral anticoagulants for the treatment of cancer-associated thrombosis
Value and limitations of low-molecular-weight heparins Following the demonstration that vitamin K antagonists (VKA) are...
MOST READ
SOCIAL
Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels Real‐world cohort of newly diagnosed patients w cancer had higher rates of VTE and lower survival with increased KS @aakonc @NicoleKuderer @ADesaiMD
Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels
This cohort study evaluated the risk of VTE and survival rates among patients newly diagnosed with cancer and stratified by Khorana score (KS) in a re...
onlinelibrary.wiley.com